These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 31807943
21. Mindfulness-based cognitive therapy v. treatment as usual in adults with ADHD: a multicentre, single-blind, randomised controlled trial. Janssen L, Kan CC, Carpentier PJ, Sizoo B, Hepark S, Schellekens MPJ, Donders ART, Buitelaar JK, Speckens AEM. Psychol Med; 2019 Jan; 49(1):55-65. PubMed ID: 29486807 [Abstract] [Full Text] [Related]
22. [Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents]. Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP. Encephale; 2005 Jan; 31(3):337-48. PubMed ID: 16142049 [Abstract] [Full Text] [Related]
23. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study. Dell'Agnello G, Maschietto D, Bravaccio C, Calamoneri F, Masi G, Curatolo P, Besana D, Mancini F, Rossi A, Poole L, Escobar R, Zuddas A, LYCY Study Group. Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683 [Abstract] [Full Text] [Related]
24. Sustained impact of a sleep intervention and moderators of treatment outcome for children with ADHD: a randomised controlled trial. Sciberras E, Mulraney M, Mensah F, Oberklaid F, Efron D, Hiscock H. Psychol Med; 2020 Jan; 50(2):210-219. PubMed ID: 30654852 [Abstract] [Full Text] [Related]
25. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Klassen AF, Miller A, Fine S. Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087 [Abstract] [Full Text] [Related]
26. Effectiveness and cost-effectiveness of a brief school-based group programme for parents of children at risk of ADHD: a cluster randomised controlled trial. Sayal K, Taylor JA, Valentine A, Guo B, Sampson CJ, Sellman E, James M, Hollis C, Daley D. Child Care Health Dev; 2016 Jul; 42(4):521-33. PubMed ID: 27272608 [Abstract] [Full Text] [Related]
27. Does maternal ADHD reduce the effectiveness of parent training for preschool children's ADHD? Sonuga-Barke EJ, Daley D, Thompson M. J Am Acad Child Adolesc Psychiatry; 2002 Jun; 41(6):696-702. PubMed ID: 12049444 [Abstract] [Full Text] [Related]
28. Multimodal treatment in children and adolescents with attention-deficit/hyperactivity disorder: a 6-month follow-up. Duric NS, Assmus J, Gundersen D, Duric Golos A, Elgen IB. Nord J Psychiatry; 2017 Jul; 71(5):386-394. PubMed ID: 28345387 [Abstract] [Full Text] [Related]
29. Mindfulness for children with ADHD and Mindful Parenting (MindChamp): Protocol of a randomised controlled trial comparing a family Mindfulness-Based Intervention as an add-on to care-as-usual with care-as-usual only. Siebelink NM, Bögels SM, Boerboom LM, de Waal N, Buitelaar JK, Speckens AE, Greven CU. BMC Psychiatry; 2018 Jul 25; 18(1):237. PubMed ID: 30045714 [Abstract] [Full Text] [Related]
30. Improving maternal mental health after a child's diagnosis of autism spectrum disorder: results from a randomized clinical trial. Feinberg E, Augustyn M, Fitzgerald E, Sandler J, Ferreira-Cesar Suarez Z, Chen N, Cabral H, Beardslee W, Silverstein M. JAMA Pediatr; 2014 Jan 25; 168(1):40-6. PubMed ID: 24217336 [Abstract] [Full Text] [Related]
31. Meditation or Medication? Mindfulness training versus medication in the treatment of childhood ADHD: a randomized controlled trial. Meppelink R, de Bruin EI, Bögels SM. BMC Psychiatry; 2016 Jul 26; 16():267. PubMed ID: 27460004 [Abstract] [Full Text] [Related]
32. HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system. Manos M, Frazier TW, Landgraf JM, Weiss M, Hodgkins P. Curr Med Res Opin; 2009 Dec 26; 25(12):3001-10. PubMed ID: 19849639 [Abstract] [Full Text] [Related]
33. Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial. Salehi B, Imani R, Mohammadi MR, Fallah J, Mohammadi M, Ghanizadeh A, Tasviechi AA, Vossoughi A, Rezazadeh SA, Akhondzadeh S. Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb 01; 34(1):76-80. PubMed ID: 19815048 [Abstract] [Full Text] [Related]
34. Effect of vitamin D supplementation as adjunctive therapy to methylphenidate on ADHD symptoms: A randomized, double blind, placebo-controlled trial. Mohammadpour N, Jazayeri S, Tehrani-Doost M, Djalali M, Hosseini M, Effatpanah M, Davari-Ashtiani R, Karami E. Nutr Neurosci; 2018 Apr 01; 21(3):202-209. PubMed ID: 27924679 [Abstract] [Full Text] [Related]
35. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder. Newcorn JH, Nagy P, Childress AC, Frick G, Yan B, Pliszka S. CNS Drugs; 2017 Nov 01; 31(11):999-1014. PubMed ID: 28980198 [Abstract] [Full Text] [Related]
36. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study. Mohammadi MR, Hafezi P, Galeiha A, Hajiaghaee R, Akhondzadeh S. Acta Med Iran; 2012 Nov 01; 50(11):723-8. PubMed ID: 23292622 [Abstract] [Full Text] [Related]
37. A mother-child intervention program in adolescent mothers and their children to improve maternal sensitivity, child responsiveness and child development (the TeeMo study): study protocol for a randomized controlled trial. Firk C, Dahmen B, Lehmann C, Niessen A, Koslowski J, Rauch G, Schwarte R, Stich K, Konrad K, Herpertz-Dahlmann B. Trials; 2015 May 27; 16():230. PubMed ID: 26012585 [Abstract] [Full Text] [Related]
38. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry; 1999 Dec 27; 56(12):1073-86. PubMed ID: 10591283 [Abstract] [Full Text] [Related]
39. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of osmotic-controlled release oral delivery system methylphenidate HCl in adults with attention-deficit/hyperactivity disorder in Japan. Takahashi N, Koh T, Tominaga Y, Saito Y, Kashimoto Y, Matsumura T. World J Biol Psychiatry; 2014 Aug 27; 15(6):488-98. PubMed ID: 24456065 [Abstract] [Full Text] [Related]
40. Newborn Behavioral Observation, maternal stress, depressive symptoms and the mother-infant relationship: results from the Northern Babies Longitudinal Study (NorBaby). Høifødt RS, Nordahl D, Landsem IP, Csifcsák G, Bohne A, Pfuhl G, Rognmo K, Braarud HC, Goksøyr A, Moe V, Slinning K, Wang CEA. BMC Psychiatry; 2020 Jun 15; 20(1):300. PubMed ID: 32539729 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]